PREVALENCE AND RISK FACTORS ASSOCIATED WITH DRUG-INDUCED LIVER INJURY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A 28-YEAR SINGLE CENTER EXPERIENCE

被引:0
|
作者
Hitawala, Asif Ali [1 ]
Manna, Zerai [2 ]
Temesgen-Oyelakin, Yenealem [2 ]
Poncio, Elaine [2 ]
Koh, Christopher [1 ]
Hasni, Sarfaraz [2 ]
Heller, Theo [3 ]
机构
[1] NIDDK, NIH, Bethesda, MD USA
[2] NIAMSD, Bethesda, MD USA
[3] NIDDK, Translat Hepatol Sect, Liver Dis Branch, NIH, Bethesda, MD USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1736-A
引用
收藏
页码:S660 / S660
页数:1
相关论文
共 50 条
  • [1] Prevalence of Hepatic Injury in Patients with Systemic Lupus Erythematosus: A 28-Year Single Center Experience
    Hitawala, Asif
    Manna, Zerai
    Temesgen-Oyelakin, Yenealem
    Poncio, Elaine
    Koh, Christopher
    Hasni, Sarfaraz
    Heller, Theo
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2906 - 2908
  • [2] Factors Associated with Peripheral Neuropathies in Patients with Systemic Lupus Erythematosus: A Single Center Experience
    Garcia-Guevara, Gabriela
    Trevino-Tello, Francisco
    Cabib, Christopher
    Contreras-Yanez, Irazu
    Chiquete, Erwin
    Diaz-Mora, Ariadna
    Fernandez-Nicoli, Yuliana
    Macias-Gallardo, Julio
    Jose Gomez-Pina, Juan
    Sandoval-Flores, Ivonne
    Fragoso-Loyo, Hilda
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Prevalence and Risk Factors for Drug-Induced Liver Injury Among Patients With Rheumatic Diseases Treated With Biological Therapy: A Single-Center Experience
    Brazdilova, K.
    Koller, T.
    Killinger, Z.
    Payer, J.
    PHYSIOLOGICAL RESEARCH, 2019, 68 : S157 - S163
  • [4] Drug-induced systemic lupus erythematosus associated with etanercept therapy
    Shakoor, N
    Michalska, M
    Harris, CA
    Block, JA
    LANCET, 2002, 359 (9306): : 579 - 580
  • [5] Prevalence and risk factors of liver biochemical abnormalities in patients with systemic lupus erythematosus
    Reem Ismail El Shazly
    Wafaa Hob Sharkawy Mohammed
    Sahar Fakhreldin Mohamed
    Mohamed Ibrahim Saif Elnasr
    Egyptian Rheumatology and Rehabilitation, 2014, 41 (4) : 139 - 147
  • [6] Infections in patients with systemic lupus erythematosus: Prevalence, spectrum and associated risk factors
    Bultink, IEM
    Dijkmans, BAC
    Voskuyl, AE
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 235 - 235
  • [7] SINGLE CENTER EXPERIENCE WITH 300 SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Tekeoglu, S.
    Karadag, D. Temiz
    Isik, O. Ozdemir
    Yazici, A.
    Cefle, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 598 - 598
  • [8] Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab
    Pérez-García, C
    Maymo, J
    Pérez, MPL
    Bernabé, MA
    Abelló, JC
    RHEUMATOLOGY, 2006, 45 (01) : 114 - 116
  • [9] Prevalence and Risk Factors for Liver Biochemical Abnormalities in Canadian Patients with Systemic Lupus Erythematosus
    Huang, Darryl
    Aghdassi, Elaheh
    Su, Jiandong
    Mosko, Jeffrey
    Hirschfield, Gideon M.
    Gladman, Dafna D.
    Urowitz, Murray B.
    Fortin, Paul R.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (02) : 254 - 261
  • [10] PREVALENCE AND DESCRIPTION OF AUTOIMMUNE POLYENDOCRINE SYNDROMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: EXPERIENCE OF A SINGLE CENTER
    Piovani, E.
    Gozzoli, G. I.
    Bizioli, P.
    Taglietti, M.
    Fredi, M.
    Cappelli, C.
    Franceschini, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1524 - 1525